Document Page: First | Prev | Next | All | Image | This Release | Search
File: 072496_jun96_decls43_0001.txt
Subject: VII CORPS GUIDANCE NERVE AGENT ANTIDOTE KIT MARK I
Unit: VII CORPS
Parent Organization: ARCENT
Box ID: BX000235
Folder Seq #: 1
Document Number: 135
UNCLASSIFIED
IMMEDIATE 6 a a i
TORm335 lik2d TOO-335 162941 MSG NBR--UF3a-014IL3
OATSZYUV RRFFXR 35161 SNHRB.
2 ft Y.
0 01121OZ DEC 90
FM CORVIICORPS HOERRIUSER SE?/AETSGC-0-CAT/,'
TO RUFLFCAICDRIDINFDIY VUERZOURG GE,?/AETS-BCCI/
RUFTLRAICDRISTARNDIY AUSBACH CE//AETS-KCGII
RUSURGAICORISTINFDIV FWD GOEPPINGER
RUFLUBAICORVIICORPSARTY AUGSBURG GE//AEtS-FA/@
RRFFHELtCDR2DCOSCON MELLINGER GEIIAETS-SC?/
ROFTAEAICDR20ACR NUERRSERC GE/IAETSAC/I
RUStINRB/CDR71NFZH-GP ATUTTGART CE/r*AETS-FG/@
14 BOE LUOVIGSBURS GE /A -P'B-//
RHFFHRatCDR930SIGBOE HEILBRONN
RUDOLUA/CDR207TONIODE LUDWIGSBURS gElaeAETS-hl/?
RUSHMILTCDRIITHAYNBDE ILLESHEIN CEIIAETS-EB?/
R H14RB/CDR77tiENGSDE LUDUIGSBUIFU GEI/AETS-EB//
RHFFHELICDR77HPERSGP MELLINGER G ,/AE.- -
RHFFMRN/CDRVIICORPSSTS HOENRINGER GE.?/AETS-ST,'/
I14FO RUDOGAA/CDR20ARKDIY FUD CARLSTEDT CEIZAEUAD-CC/I
RHFFDRKICDR3DARNDIV PRIAHKFURT GE4PIAETY-TFI/
RHFFAAAICDRYCORPS FRANKFURT GE@l$iETY-SU/I
RHFFMRHIPCDRVIICORPS HOEBRINGEN SE?/AETSSU?/
PAGE 132 RHFFMRHODQB
VI kIT MARK I (HAAK)
A. ARMY MEDICAL MATERIEL AGENCY, EIIROPEP AENMR-QC 11-18,
10153OZ NOY 904 SUBJECT QUALITY CONTROL DIRECTIVE 80 9U-412.
1. IN NOY 90 ALL USAREUR STOCKS OF NERVE AGENT ANTIDOTE KIT
MARK I CHAAKI EXPIRED. MSG A PROYIDED EXTENDED SHELF LIFE (ESL)
INFORMATION OH SOME 75 LOT NUMBERS EFFECTED. QUANTITIES EXTENDED AND
THOSE AYAILABLE FROM USAREUR STOCKS ARE NOT SUFFICIENT TO PROVIDE
THREE (3) ESL KITS FOR EACH SOLDIER DEPLOYING TO DESERT SHIELD.
2. l@U USAREUR GUIDANCE, VII CORPS SOLDIERS VILL DEPLOY WITH
THREE (3) MARK I HAAKS, URICH AT LEAST ONE- REPEATA %%I LEAST ONE VILL
BE AN ESL KIT.
(U) THE FDA STANDARD FOR EXTENDING A KIT IS THE ABILITY TO
DELIVER AT LEAST 92% OF THE STATED DOSE PER INJECTOR. THIS IS THE
STANDARD FOR HOSPITAL PRODUCTS. CONSIDERING THE PROJECTED USE OF THE
MARK I KIT, THE FDA HAS NOV AGREED TO LOVER THIS STANDARD TO A5% OF
THE DOSE PER INJECTIONS WHICH IS REASONABLE CONSIDERING THE HANNER OF
USE AND THE LOU LIKELIHOOD THAT ALL THREE (3) IHJPCTORS WOULD
ACTUALLY BE REQUIRED TO BLOCK IIERVE AGE14T EFFECTS IN A PREPARED
DECLASSIFIED
ON: II JUL 96
BY: SEC ARMY (DAIAH) UNDER
,GE@3-4 Et) 12958
ltl"EDIATE r U
-AID,
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 2 f:/Week-25/BX000235/7TH EN BDE TOC LOG NUMBER 9 5 DEC 90/vii corps guidance nerve agent antidote kit mark:07199610202071
Control Fields 17
File Room = jun96_declassified
File Cabinet = Week-25
Box ID = BX000235
Unit = VII CORPS
Parent Organization = ARCENT
Folder Title = 7TH EN BDE TOC LOG NUMBER 9 5 DEC 90
Folder Seq # = 1
Subject = VII CORPS GUIDANCE NERVE AGENT ANTIDOTE KIT MARK
Document Seq # = 71
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 19-JUL-1996